IconOVir

0 followers


IconOVir Bio is a preclinical-stage biotechnology company pioneering the next generation of oncolytic virus therapy to improve the treatment of patients with cancer.

Industries

Headquarters

Stage

Employees

Links

Org chart

Mark McCamish
President & CEO

Mark McCamish

Collapse
John Huynh
Chief Technology Officer
Heba Nowyhed
SVP, Research
Christopher Wilfong
Corporate Development & Strategy Advisor
Sean Algeo
Controller & Treasurer
Nicole Van De Leuv
Head of Legal
Julie Maltzman
Chief Medical Officer
Dustin Wright
Vice President, Clinical Operations